EDWARD D KING MD NPI 1205834728

NPI Details

Edward D King, MD is an urology in Ocala, FL with 36 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. Edward D King, MD NPI is 1205834728. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1990

The provider's business location address is:

1901 SE 18TH AVE
BLDG 300
OCALA, FL
ZIP 34471-215
Phone: (352) 351-1313
Fax: (352) 351-1285

The NPI 1205834728 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, degarelix, 1 mg (HCPCS:J9155)
• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml (HCPCS:A9579)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Mri scan of pelvis without contrast (HCPCS:72195)
• Mri scan of pelvis before and after contrast (HCPCS:72197)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Biopsy of prostate gland (HCPCS:55700)
• Injection procedure to cause erection (HCPCS:54235)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm (HCPCS:52235)
• Exam with injections of chemical for destruction of bladder using an endoscope (HCPCS:52287)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Complete laser vaporization of prostate including control of bleeding using an endoscope (HCPCS:52648)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm (HCPCS:52234)
• Prostate resection (HCPCS:NAN14)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 7/8/2005 and was last updated on 1/5/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.